Cargando…
Desmoglein 2 promotes vasculogenic mimicry in melanoma and is associated with poor clinical outcome
Tumors can develop a blood supply not only by promoting angiogenesis but also by forming vessel-like structures directly from tumor cells, known as vasculogenic mimicry (VM). Understanding mechanisms that regulate VM is important, as these might be exploitable to inhibit tumor progression. Here, we...
Autores principales: | Tan, Lih Yin, Mintoff, Chris, Johan, M. Zahied, Ebert, Brenton W., Fedele, Clare, Zhang, You Fang, Szeto, Pacman, Sheppard, Karen E., McArthur, Grant A., Foster-Smith, Erwin, Ruszkiewicz, Andrew, Brown, Michael P., Bonder, Claudine S., Shackleton, Mark, Ebert, Lisa M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216812/ https://www.ncbi.nlm.nih.gov/pubmed/27340778 http://dx.doi.org/10.18632/oncotarget.10216 |
Ejemplares similares
-
Vasculogenic mimicry structures in melanoma support the recruitment of monocytes
por: Tan, Lih Y., et al.
Publicado: (2022) -
Desmoglein‐2 expression is an independent predictor of poor prognosis patients with multiple myeloma
por: Ebert, Lisa M., et al.
Publicado: (2021) -
CD36 promotes vasculogenic mimicry in melanoma by mediating adhesion to the extracellular matrix
por: Martini, Carmela, et al.
Publicado: (2021) -
A non-canonical role for desmoglein-2 in endothelial cells: implications for neoangiogenesis
por: Ebert, Lisa M., et al.
Publicado: (2016) -
Platelets disrupt vasculogenic mimicry by cancer cells
por: Martini, Carmela, et al.
Publicado: (2020)